" You might get your own people up and running, but do you have a vendor that's NOT going to be available?"

You're prepared, but what happens if your business-critical vendor isn't? Amy Vetter hosts this month's Cyber Security Advisory discussion. With panellists Audrey Katcher of Ruben Brown and Torpey White of WipFli, they explore vendor risk management, and suggest three key action items which your teams can begin working on immediately.

Talking Points. These are just some of the topics discussed in this episode.

Best practices for security and supply chains.
Vendor due diligence,
What that actually means in practice,
How risk should be monitored during the COVID-19 pandemic

Resources. Use these links to find out more about this topic, or to access free guidance and resources to implement in your own team or organisation.

- Find technology and cybersecurity resources on the AICPA Technology Hub.
- Discover more detailed information and guidance about Cybersecurity and Information Security.
- Visit dedicated coronavirus online resource centres for our AICPA and CIMA networks.
- Can't see the links? Visit https://future.aicpa.org/topic/technology and https://www.aicpa.org/coronavirus.

Share. Know someone who should hear this podcast? Click on these links to automatically share this episode with colleagues and friends. Recommend it to your LinkedIn connections, send to Twitter, auto-share on your Facebook page, or simply tell someone via email.

Social. Use #GoBeyondDisruption, @AICPANews or @CIMA_News.

About Our Podcast. These conversations with expert guests are recorded by different members of the AICPA & CIMA team from our offices around the world. While the sound quality may vary, we hope that the insights will be consistently useful.

Get in touch. How did you discover our podcast? Where do you listen? What would you like to hear more of? Finance pro or not, we're keen to know what you think. Email us here.

©2018-2020 Association of International Certified Professional Accountants (AICPA & CIMA)

Anticholinergika und Demenz